Antibiotic Susceptibility Pattern of Extended-Spectrum Beta-Lactamase-Producing Klebsiella Pneumoniae and Escherichia Coli
DOI:
https://doi.org/10.24293/ijcpml.v27i3.1634Keywords:
Extended-spectrum beta-lactamase, Klebsiella pneumoniae, Escherichia coli, antibiotics susceptibility pattern, intensive care unitsAbstract
Extended-Spectrum Beta-Lactamase (ESBL) producing bacteria is a type of resistance that leads to complex management of patients in intensive care due to their resistance to first, second, and third-generation Cephalosporin and monobactam antibiotics. The most ESBL-producing bacteria are found in the family Enterobacteriaceae, especially Klebsiella pneumoniae and Escherichia coli. The purpose of this research was to determine the sensitivity pattern of ESBLproducing bacteria in Intensive Care Units (ICUs) of Ulin Hospital, Banjarmasin, in the period of 2016-2018. This research was a descriptive study with a cross-sectional approach using data from the laboratory medical records of patients with positive ESBL in the ICUs of Ulin Hospital, Banjarmasin, between 2016 and 2018. The research sample was taken by the total sampling method. This research obtained 216 isolates of ESBL-producing bacteria consisting of 155 (71.8%) isolates of Klebsiella pneumoniae and 61 (28.2%) Escherichia coli. It was found that the Cephalosporin antibiotics (Cefazolin, Ceftazidime, Ceftriaxone, and Cefepime) and monobactam antibiotic (Aztreonam) had the lowest sensitivity. Aminoglycoside antibiotics (Amikacin), Carbapenem (Ertapenem and Meropenem), and Tetracycline (Tigesycline) were the most sensitive antibiotics. It was concluded that both Klebsiella pneumoniae and Escherichia coli were the most dominant ESBL-producing bacteria and showed good sensitivity to the Amikacin, Ertapenem, Meropenem, and Tigecycline.
Downloads
References
Khan HA, Baig FK, Mehboob R. Nosocomial infections: epidemiology, prevention, control dan surveillance. Asian Pac J Trop Biomed, 2017; 7(5): 478-9.
Taslim, Emilzon, Tinni T. Maskoen. Pola kuman terbanyak sebagai agen penyebab infeksi di intensive
care unit pada beberapa rumah sakit di Indonesia. Perdatin, 2016; 34: 57-8.
Kambuno, Norma Tiku, Dicky Fanggidae. Identifikasi bakteri Gram-negatif galur extended-spectrum
beta-lactamase pada ruang NICU RSUD Prof. DR. W. Z. Johannes Kupang. JIK, 2017; 15: 334-341.
Tsai MH, Chu SM, Hsu JF, Lien R, Huang HR, et al. Risk factors and outcomes for multidrug-resistant
Gram-negative bacteremia in the NICU. Pediatrics, 2014; 133(2): 324-6.
Folgore L, Bielicki J, Heath PT, Sharland M. Antimicrobial-resistant Gram-negative infections in
neonates: Burden of disease and challenges in treatment. Curr Opin Infect Dis, 2017; 30: 2-3.
Anggraini D, Uswatun HS, Maya S, Fauzia AD, Dino I, Ruza PR. Prevalensi dan pola sensitivitas
enterobacteriaceae penghasil ESBL di RSUD Arifin Achmad Pekanbaru. JKB, 2017; 30(1): 48.
Muhajir, Ahmad Siddiq, Priyo Budi Purwono, Samsriyaningsih Handayani. Gambaran terapi luaran
infeksi saluran kemih oleh bakteri penghasil extended- spectrum beta-lactamase pada anak di
RSUD Dr. Soetomo Surabaya. Sari Pediatri, 2016; 18(2): 112-4.
Kiddie A, Assawatheptawee K, Na-udom A, Boonsawang P. Risk factor for extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage inpatient admitted to intensive care unit in a tertiary care hospital in Thailand. MDR, 2019: 1-3.
Bindu MH, Kasturi T, Reddy M, Indu K. Prevalence of ESBL Production in Escherichia coli and Klebsiella spp. from different clinical samples–A study in a teaching hospital in Telangana, India. IJCMAS, 2015; 4(3): 236-7.
Padmini N, Ajilda AAK, Sivakumar N, Selvakumar G. Extended-spectrum beta-lactamase-producing
Escherichia coli and Klebsiella pneumoniae: Critical tools for antibiotic resistance pattern. J Basic
Microbiol, 2017; 57: 464-5.
Sinanjung K, Aman AT, Nirwati H. Proporsi Klebsiella pneumoniae isolat klinik penghasil Extended-Spectrum Beta Lactamase (ESBL) beserta pola kepekaannya terhadap antibiotika di RSUP Dr. Soeradji Tirtonegoro Klaten. Yogyakarta, Fakultas Kedokteran Universitas Gadjah Mada, 2019. (Tesis).
Luyt CE, Hékimian G, Koulenti D, Chastre J. Microbial cause of ICU-acquired pneumonia: Hospital-acquired pneumonia versus ventilator-associated pneumonia. Curr Opin Crit Care, 2018; 24(5): 333-334.
Sansom D, Merchant AT, Wara-Aswapati N, Ruaisungnoen W, Pitiphat W. Oral health and
ventilator-associated pneumonia among critically ill patients: A prospective study. Oral Dis, 2016; 22(7):
-14.
European Centre for Disease Prevention and Control. Introduction to the annual epidemiological report for 2015. In: ECDC. Annual epidemiological report for 2015. Stockholm, ECDC, 2017. Available from: https://ecdc.europa.eu/en/publications-data/healthcare-associated-infections-acquired-intensive
-care-units-annual (accessed 9 November, 2018).
Carrol KC, Hobden JA, Mietzner T, Miller S. Jawetz, th Melnick, and Adelberg's Medical Microbiology. 27 Ed., New York, McGraw-Hill Education, 2016; 383-7.
Sah SK, Hemalatha S. Extended-Spectrum Beta-Lactamase (ESBL) mechanism of antibiotic
resistance and epidemiology. Int. J PharmTech Research, 2015; 7(2): 304.
Fauziyah, Siti, Maksum Radji, Nurgani A. Hubungan penggunaan antibiotika pada terapi empiris dengan kepekaan bakteri di ICU RSUP Fatmawati Jakarta. JFI, 2011; 5(3): 158.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.